AVDL
Avadel Pharmaceuticals
AVDL
AVDL
83 hedge funds and large institutions have $239M invested in Avadel Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 76 → 83 (+7)
1% more ownership
Funds ownership: 53.16% → 54.15% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
83
Holding in Top 10
2
Calls
$13.7M
Puts
$12.3M
Top Buyers
| 1 | +$8.63M | |
| 2 | +$4.9M | |
| 3 | +$4.36M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.7M |
| 5 |
GJL
Gendell Jeffrey L
|
+$2.39M |
Top Sellers
| 1 | -$7.48M | |
| 2 | -$2.07M | |
| 3 | -$1.31M | |
| 4 |
Two Sigma Investments
New York
|
-$759K |
| 5 |
Renaissance Technologies
New York
|
-$738K |